Table of Contents 1 Market Overview 1.1 Human Vaccine Adjuvants Introduction 1.2 Market Analysis by Type 1.2.1 Overview: Global Human Vaccine Adjuvants Revenue by Type: 2015 VS 2019 VS 2025 1.2.2 Oral 1.2.3 Subcutaneous 1.2.4 Intramuscular 1.2.5 Others 1.3 Market Analysis by Application 1.3.1 Overview: Global Human Vaccine Adjuvants Revenue by Application: 2015 VS 2019 VS 2025 1.3.2 Research Applications 1.3.3 Commercial Applications 1.4 Overview of Global Human Vaccine Adjuvants Market 1.4.1 Global Human Vaccine Adjuvants Market Status and Outlook (2015-2025) 1.4.2 North America (United States, Canada and Mexico) 1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy) 1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.5 South America, Middle East & Africa 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 GSK 2.1.1 GSK Details 2.1.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis 2.1.3 GSK SWOT Analysis 2.1.4 GSK Product and Services 2.1.5 GSK Human Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.2 Aphios 2.2.1 Aphios Details 2.2.2 Aphios Major Business and Total Revenue (Financial Highlights) Analysis 2.2.3 Aphios SWOT Analysis 2.2.4 Aphios Product and Services 2.2.5 Aphios Human Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.3 SEPPIC 2.3.1 SEPPIC Details 2.3.2 SEPPIC Major Business and Total Revenue (Financial Highlights) Analysis 2.3.3 SEPPIC SWOT Analysis 2.3.4 SEPPIC Product and Services 2.3.5 SEPPIC Human Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.4 CSL Limited 2.4.1 CSL Limited Details 2.4.2 CSL Limited Major Business and Total Revenue (Financial Highlights) Analysis 2.4.3 CSL Limited SWOT Analysis 2.4.4 CSL Limited Product and Services 2.4.5 CSL Limited Human Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.5 Avanti Polar Lipids 2.5.1 Avanti Polar Lipids Details 2.5.2 Avanti Polar Lipids Major Business and Total Revenue (Financial Highlights) Analysis 2.5.3 Avanti Polar Lipids SWOT Analysis 2.5.4 Avanti Polar Lipids Product and Services 2.5.5 Avanti Polar Lipids Human Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.6 Brenntag Biosector 2.6.1 Brenntag Biosector Details 2.6.2 Brenntag Biosector Major Business and Total Revenue (Financial Highlights) Analysis 2.6.3 Brenntag Biosector SWOT Analysis 2.6.4 Brenntag Biosector Product and Services 2.6.5 Brenntag Biosector Human Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.7 Novavax 2.7.1 Novavax Details 2.7.2 Novavax Major Business and Total Revenue (Financial Highlights) Analysis 2.7.3 Novavax SWOT Analysis 2.7.4 Novavax Product and Services 2.7.5 Novavax Human Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.8 SPI Pharma 2.8.1 SPI Pharma Details 2.8.2 SPI Pharma Major Business and Total Revenue (Financial Highlights) Analysis 2.8.3 SPI Pharma SWOT Analysis 2.8.4 SPI Pharma Product and Services 2.8.5 SPI Pharma Human Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 3 Sales, Revenue and Market Share by Manufacturer 3.1 Global Human Vaccine Adjuvants Sales and Market Share by Manufacturer (2018-2019) 3.2 Global Human Vaccine Adjuvants Revenue and Market Share by Manufacturer (2018-2019) 3.3 Market Concentration Rate 3.3.1 Top 3 Human Vaccine Adjuvants Manufacturer Market Share in 2019 3.3.2 Top 6 Human Vaccine Adjuvants Manufacturer Market Share in 2019 3.4 Market Competition Trend 4 Global Market Analysis by Regions 4.1 Global Human Vaccine Adjuvants Sales, Revenue and Market Share by Regions 4.1.1 Global Human Vaccine Adjuvants Sales and Market Share by Regions (2015-2020) 4.1.2 Global Human Vaccine Adjuvants Revenue and Market Share by Regions (2015-2020) 4.2 North America Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) 4.3 Europe Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) 4.4 Asia-Pacific Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) 4.5 South America Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) 4.6 Middle East and Africa Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) 5 North America by Country 5.1 North America Human Vaccine Adjuvants Sales, Revenue and Market Share by Country 5.1.1 North America Human Vaccine Adjuvants Sales and Market Share by Country (2015-2020) 5.1.2 North America Human Vaccine Adjuvants Revenue and Market Share by Country (2015-2020) 5.2 United States Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) 5.3 Canada Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) 5.4 Mexico Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) 6 Europe by Country 6.1 Europe Human Vaccine Adjuvants Sales, Revenue and Market Share by Country 6.1.1 Europe Human Vaccine Adjuvants Sales and Market Share by Country (2015-2020) 6.1.2 Europe Human Vaccine Adjuvants Revenue and Market Share by Country (2015-2020) 6.2 Germany Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) 6.3 UK Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) 6.4 France Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) 6.5 Russia Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) 6.6 Italy Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) 7 Asia-Pacific by Regions 7.1 Asia-Pacific Human Vaccine Adjuvants Sales, Revenue and Market Share by Regions 7.1.1 Asia-Pacific Human Vaccine Adjuvants Sales and Market Share by Regions (2015-2020) 7.1.2 Asia-Pacific Human Vaccine Adjuvants Revenue and Market Share by Regions (2015-2020) 7.2 China Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) 7.3 Japan Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) 7.4 Korea Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) 7.5 India Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) 7.6 Southeast Asia Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) 7.7 Australia Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) 8 South America by Country 8.1 South America Human Vaccine Adjuvants Sales, Revenue and Market Share by Country 8.1.1 South America Human Vaccine Adjuvants Sales and Market Share by Country (2015-2020) 8.1.2 South America Human Vaccine Adjuvants Revenue and Market Share by Country (2015-2020) 8.2 Brazil Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) 8.3 Argentina Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) 9 Middle East & Africa by Countries 9.1 Middle East & Africa Human Vaccine Adjuvants Sales, Revenue and Market Share by Country 9.1.1 Middle East & Africa Human Vaccine Adjuvants Sales and Market Share by Country (2015-2020) 9.1.2 Middle East & Africa Human Vaccine Adjuvants Revenue and Market Share by Country (2015-2020) 9.2 Saudi Arabia Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) 9.3 Turkey Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) 9.4 Egypt Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) 9.5 South Africa Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) 10 Market Segment by Type 10.1 Global Human Vaccine Adjuvants Sales and Market Share by Type (2015-2020) 10.2 Global Human Vaccine Adjuvants Revenue and Market Share by Type (2015-2020) 10.3 Global Human Vaccine Adjuvants Price by Type (2015-2020) 11 Global Human Vaccine Adjuvants Market Segment by Application 11.1 Global Human Vaccine Adjuvants Sales Market Share by Application (2015-2020) 11.2 Global Human Vaccine Adjuvants Revenue Market Share by Application (2015-2020) 11.3 Global Human Vaccine Adjuvants Price by Application (2015-2020) 12 Market Forecast 12.1 Global Human Vaccine Adjuvants Sales, Revenue and Growth Rate (2021-2025) 12.2 Human Vaccine Adjuvants Market Forecast by Regions (2021-2025) 12.2.1 North America Human Vaccine Adjuvants Market Forecast (2021-2025) 12.2.2 Europe Human Vaccine Adjuvants Market Forecast (2021-2025) 12.2.3 Asia-Pacific Human Vaccine Adjuvants Market Forecast (2021-2025) 12.2.4 South America Human Vaccine Adjuvants Market Forecast (2021-2025) 12.2.5 Middle East & Africa Human Vaccine Adjuvants Market Forecast (2021-2025) 12.3 Human Vaccine Adjuvants Market Forecast by Type (2021-2025) 12.3.1 Global Human Vaccine Adjuvants Sales Forecast by Type (2021-2025) 12.3.2 Global Human Vaccine Adjuvants Market Share Forecast by Type (2021-2025) 12.4 Human Vaccine Adjuvants Market Forecast by Application (2021-2025) 12.4.1 Global Human Vaccine Adjuvants Sales Forecast by Application (2021-2025) 12.4.2 Global Human Vaccine Adjuvants Market Share Forecast by Application (2021-2025) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source 15.3 Disclaimer 15.4 About US

List of Tables Table 1. Global Human Vaccine Adjuvants Revenue (USD Million) by Type: 2015 VS 2019 VS 2025 Table 2. Breakdown of Human Vaccine Adjuvants by Company Type (Tier 1, Tier 2 and Tier 3) Table 3. Global Human Vaccine Adjuvants Revenue (USD Million) by Application: 2015 VS 2019 VS 2025 Table 4. Market Opportunities in Next Few Years Table 5. Market Risks Analysis Table 6. Market Drivers Table 7. GSK Basic Information, Manufacturing Base and Competitors Table 8. GSK Human Vaccine Adjuvants Major Business Table 9. GSK Human Vaccine Adjuvants Total Revenue (USD Million) (2017-2018) Table 10. GSK SWOT Analysis Table 11. GSK Human Vaccine Adjuvants Product and Services Table 12. GSK Human Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 13. Aphios Basic Information, Manufacturing Base and Competitors Table 14. Aphios Human Vaccine Adjuvants Major Business Table 15. Aphios Human Vaccine Adjuvants Total Revenue (USD Million) (2017-2018) Table 16. Aphios SWOT Analysis Table 17. Aphios Human Vaccine Adjuvants Product and Services Table 18. Aphios Human Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 19. SEPPIC Basic Information, Manufacturing Base and Competitors Table 20. SEPPIC Human Vaccine Adjuvants Major Business Table 21. SEPPIC Human Vaccine Adjuvants Total Revenue (USD Million) (2017-2018) Table 22. SEPPIC SWOT Analysis Table 23. SEPPIC Human Vaccine Adjuvants Product and Services Table 24. SEPPIC Human Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 25. CSL Limited Basic Information, Manufacturing Base and Competitors Table 26. CSL Limited Human Vaccine Adjuvants Major Business Table 27. CSL Limited Human Vaccine Adjuvants Total Revenue (USD Million) (2017-2018) Table 28. CSL Limited SWOT Analysis Table 29. CSL Limited Human Vaccine Adjuvants Product and Services Table 30. CSL Limited Human Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 31. Avanti Polar Lipids Basic Information, Manufacturing Base and Competitors Table 32. Avanti Polar Lipids Human Vaccine Adjuvants Major Business Table 33. Avanti Polar Lipids Human Vaccine Adjuvants Total Revenue (USD Million) (2017-2018) Table 34. Avanti Polar Lipids SWOT Analysis Table 35. Avanti Polar Lipids Human Vaccine Adjuvants Product and Services Table 36. Avanti Polar Lipids Human Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 37. Brenntag Biosector Basic Information, Manufacturing Base and Competitors Table 38. Brenntag Biosector Human Vaccine Adjuvants Major Business Table 39. Brenntag Biosector Human Vaccine Adjuvants Total Revenue (USD Million) (2017-2018) Table 40. Brenntag Biosector SWOT Analysis Table 41. Brenntag Biosector Human Vaccine Adjuvants Product and Services Table 42. Brenntag Biosector Human Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 43. Novavax Basic Information, Manufacturing Base and Competitors Table 44. Novavax Human Vaccine Adjuvants Major Business Table 45. Novavax Human Vaccine Adjuvants Total Revenue (USD Million) (2017-2018) Table 46. Novavax SWOT Analysis Table 47. Novavax Human Vaccine Adjuvants Product and Services Table 48. Novavax Human Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 49. SPI Pharma Basic Information, Manufacturing Base and Competitors Table 50. SPI Pharma Human Vaccine Adjuvants Major Business Table 51. SPI Pharma Human Vaccine Adjuvants Total Revenue (USD Million) (2017-2018) Table 52. SPI Pharma SWOT Analysis Table 53. SPI Pharma Human Vaccine Adjuvants Product and Services Table 54. SPI Pharma Human Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 55. Global Human Vaccine Adjuvants Sales by Manufacturer (2018-2019) (MT) Table 56. Global Human Vaccine Adjuvants Revenue by Manufacturer (2018-2019) (USD Million) Table 57. Global Human Vaccine Adjuvants Sales by Regions (2015-2020) (MT) Table 58. Global Human Vaccine Adjuvants Sales Market Share by Regions (2015-2020) Table 59. Global Human Vaccine Adjuvants Revenue by Regions (2015-2020) (USD Million) Table 60. North America Human Vaccine Adjuvants Sales by Countries (2015-2020) (MT) Table 61. North America Human Vaccine Adjuvants Sales Market Share by Countries (2015-2020) Table 62. North America Human Vaccine Adjuvants Revenue by Countries (2015-2020) (USD Million) Table 63. North America Human Vaccine Adjuvants Revenue Market Share by Countries (2015-2020) Table 64. Europe Human Vaccine Adjuvants Sales by Countries (2015-2020) (MT) Table 65. Europe Human Vaccine Adjuvants Sales Market Share by Countries (2015-2020) Table 66. Europe Human Vaccine Adjuvants Revenue by Countries (2015-2020) (USD Million) Table 67. Asia-Pacific Human Vaccine Adjuvants Sales by Regions (2015-2020) (MT) Table 68. Asia-Pacific Human Vaccine Adjuvants Sales Market Share by Regions (2015-2020) Table 69. Asia-Pacific Human Vaccine Adjuvants Revenue by Regions (2015-2020) (USD Million) Table 70. South America Human Vaccine Adjuvants Sales by Countries (2015-2020) (MT) Table 71. South America Human Vaccine Adjuvants Sales Market Share by Countries (2015-2020) Table 72. South America Human Vaccine Adjuvants Revenue by Countries (2015-2020) (USD Million) Table 73. South America Human Vaccine Adjuvants Revenue Market Share by Countries (2015-2020) Table 74. Middle East & Africa Human Vaccine Adjuvants Sales by Countries (2015-2020) (MT) Table 75. Middle East & Africa Human Vaccine Adjuvants Sales Market Share by Countries (2015-2020) Table 76. Middle East & Africa Human Vaccine Adjuvants Revenue by Countries (2015-2020) (USD Million) Table 77. Middle East & Africa Human Vaccine Adjuvants Revenue Market Share by Countries (2015-2020) Table 78. Global Human Vaccine Adjuvants Sales by Type (2015-2020) (MT) Table 79. Global Human Vaccine Adjuvants Sales Share by Type (2015-2020) Table 80. Global Human Vaccine Adjuvants Revenue by Type (2015-2020) (USD Million) Table 81. Global Human Vaccine Adjuvants Revenue Share by Type (2015-2020) Table 82. Global Human Vaccine Adjuvants Sales by Application (2015-2020) (MT) Table 83. Global Human Vaccine Adjuvants Sales Share by Application (2015-2020) Table 84. Global Human Vaccine Adjuvants Sales Forecast by Regions (2021-2025) (MT) Table 85. Global Human Vaccine Adjuvants Market Share Forecast by Regions (2021-2025) Table 86. Global Human Vaccine Adjuvants Sales Forecast by Type (2021-2025) (MT) Table 87. Global Human Vaccine Adjuvants Market Share Forecast by Type (2021-2025) Table 88. Global Human Vaccine Adjuvants Sales Forecast by Application (2021-2025) Table 89. Global Human Vaccine Adjuvants Market Share Forecast by Application (2021-2025) Table 90. Direct Channel Pros & Cons Table 91. Indirect Channel Pros & Cons Table 92. Distributors/Traders/ Dealers List List of Figures Figure 1. Human Vaccine Adjuvants Picture Figure 2. Global Sales Market Share of Human Vaccine Adjuvants by Type in 2019 Figure 3. Oral Picture Figure 4. Subcutaneous Picture Figure 5. Intramuscular Picture Figure 6. Others Picture Figure 7. Human Vaccine Adjuvants Sales Market Share by Application in 2018 Figure 8. Research Applications Picture Figure 9. Commercial Applications Picture Figure 10. Global Human Vaccine Adjuvants Market Status and Outlook (2015-2025) (USD Million) Figure 11. United States Human Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025) Figure 12. Canada Human Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025) Figure 13. Mexico Human Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025) Figure 14. Germany Human Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025) Figure 15. France Human Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025) Figure 16. UK Human Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025) Figure 17. Russia Human Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025) Figure 18. Italy Human Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025) Figure 19. China Human Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025) Figure 20. Japan Human Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025) Figure 21. Korea Human Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025) Figure 22. India Human Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025) Figure 23. Southeast Asia Human Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025) Figure 24. Australia Human Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025) (USD Million) Figure 25. Brazil Human Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025) Figure 26. Egypt Human Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025) Figure 27. Saudi Arabia Human Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025) Figure 28. South Africa Human Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025) Figure 29. Turkey Human Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025) Figure 30. Global Human Vaccine Adjuvants Sales Market Share by Manufacturer in 2019 Figure 31. Global Human Vaccine Adjuvants Revenue Market Share by Manufacturer in 2019 Figure 32. Top 3 Human Vaccine Adjuvants Manufacturer (Revenue) Market Share in 2019 Figure 33. Top 6 Human Vaccine Adjuvants Manufacturer (Revenue) Market Share in 2019 Figure 34. Key Manufacturer Market Share Trend Figure 35. Global Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) (MT) Figure 36. Global Human Vaccine Adjuvants Revenue and Growth Rate (2015-2020) (USD Million) Figure 37. Global Human Vaccine Adjuvants Revenue Market Share by Regions (2015-2020) Figure 38. Global Human Vaccine Adjuvants Revenue Market Share by Regions in 2018 Figure 39. North America Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) Figure 40. Europe Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) Figure 41. Asia-Pacific Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) Figure 42. South America Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) Figure 43. Middle East & Africa Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) Figure 44. North America Human Vaccine Adjuvants Revenue and Growth Rate (2015-2020) (USD Million) Figure 45. North America Human Vaccine Adjuvants Sales Market Share by Countries (2015-2020) Figure 46. North America Human Vaccine Adjuvants Sales Market Share by Countries in 2018 Figure 47. North America Human Vaccine Adjuvants Revenue Market Share by Countries (2015-2020) (USD Million) Figure 48. North America Human Vaccine Adjuvants Revenue Market Share by Countries in 2018 Figure 49. United States Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) (MT) Figure 50. Canada Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) (MT) Figure 51. Mexico Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) (MT) Figure 52. Europe Human Vaccine Adjuvants Revenue and Growth Rate (2015-2020) (USD Million) Figure 53. Europe Human Vaccine Adjuvants Revenue Market Share by Countries (2015-2020) Figure 54. Europe Human Vaccine Adjuvants Revenue Market Share by Countries in 2019 Figure 55. Germany Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) (MT) Figure 56. UK Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) (MT) Figure 57. France Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) (MT) Figure 58. Russia Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) (MT) Figure 59. Italy Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) (MT) Figure 60. Asia-Pacific Human Vaccine Adjuvants Revenue and Growth Rate (2015-2020) (USD Million) Figure 61. Asia-Pacific Human Vaccine Adjuvants Sales Market Share by Regions 2019 Figure 62. Asia-Pacific Human Vaccine Adjuvants Revenue Market Share by Regions 2019 Figure 63. China Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) (MT) Figure 64. Japan Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) (MT) Figure 65. Korea Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) (MT) Figure 66. India Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) (MT) Figure 67. Southeast Asia Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) (MT) Figure 68. South America Human Vaccine Adjuvants Revenue and Growth Rate (2015-2020) (USD Million) Figure 69. South America Human Vaccine Adjuvants Sales Market Share by Countries in 2019 Figure 70. South America Human Vaccine Adjuvants Revenue Market Share by Countries in 2019 Figure 71. Brazil Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) (MT) Figure 72. Argentina Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) (MT) Figure 73. Middle East and Africa Human Vaccine Adjuvants Revenue and Growth Rate (2015-2020) (USD Million) Figure 74. Middle East and Africa Human Vaccine Adjuvants Sales Market Share by Countries in 2019 Figure 75. Middle East and Africa Human Vaccine Adjuvants Revenue Market Share by Countries (2015-2020) Figure 76. Middle East and Africa Human Vaccine Adjuvants Revenue Market Share by Countries in 2019 Figure 77. Saudi Arabia Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) (MT) Figure 78. Egypt Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) (MT) Figure 79. Turkey Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) (MT) Figure 80. South Africa Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) (MT) Figure 81. Global Human Vaccine Adjuvants Sales and Growth Rate (2021-2025) (MT) Figure 82. Global Human Vaccine Adjuvants Revenue and Growth Rate (2021-2025) (USD Million) Figure 83. North America Sales Human Vaccine Adjuvants Market Forecast (2021-2025) (MT) Figure 84. Europe Sales Human Vaccine Adjuvants Market Forecast (2021-2025) (MT) Figure 85. Asia-Pacific Sales Human Vaccine Adjuvants Market Forecast (2021-2025) (MT) Figure 86. South America Sales Human Vaccine Adjuvants Market Forecast (2021-2025) (MT) Figure 87. Middle East & Africa Sales Human Vaccine Adjuvants Market Forecast (2021-2025) (MT) Figure 88. Sales Channel: Direct Channel vs Indirect Channel

GSK Aphios SEPPIC CSL Limited Avanti Polar Lipids Brenntag Biosector Novavax SPI Pharma